Common Contracts
4 similar Purchase Agreement contracts by BridgeBio Pharma, Inc., Caci International Inc /De/, Palo Alto Networks Inc, Verigy Ltd.
BridgeBio Pharma, Inc. Purchase AgreementPurchase Agreement • March 6th, 2020 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • New York
BridgeBio Pharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $475,000,000 principal amount of its 2.500% Convertible Senior Notes due 2027 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $75,000,000 principal amount of its 2.500% Convertible Senior Notes due 2027 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 2.500% Convertible Senior Notes due 2027 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underlying Securities”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), or a comb
Palo Alto Networks, Inc. 0% Convertible Senior Notes due 2019 Purchase AgreementPurchase Agreement • June 26th, 2014 • Palo Alto Networks Inc • Computer peripheral equipment, nec • New York
Palo Alto Networks, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $500,000,000 aggregate principal amount of its 0% Convertible Senior Notes due 2019 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $75,000,000 aggregate principal amount of its 0% Convertible Senior Notes due 2019 (the “Option Securities”), solely to cover overallotments, if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 0% Convertible Senior Notes due 2019 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash and shares, if any, (the “Underlying Securities”) of common stock of the Compan
VERIGY LTD. Purchase AgreementPurchase Agreement • July 15th, 2009 • Verigy Ltd. • Semiconductors & related devices • New York
Verigy Ltd., a company incorporated under the laws of the Republic of Singapore (the “Company”), has pursuant to the terms of an engagement letter dated July 7, 2009 (the “Engagement Letter”) engaged J.P. Morgan (S.E.A.) Limited, a company incorporated under the laws of the Republic of Singapore bearing the registration number 198500154W, and Morgan Stanley Asia (Singapore) Pte., a company incorporated under the laws of the Republic of Singapore bearing the registration number 199206298Z, as joint lead managers (the “Joint Lead Managers”). Pursuant to the Engagement Letter, the Joint Lead Managers have arranged the issue and sale of the Securities to the Initial Purchasers (both terms as defined below). The Company proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $120,000,000 aggregate principal amount of its 5.25% Convertible Senior Notes due 2014 (th
CACI International Inc Purchase AgreementPurchase Agreement • May 16th, 2007 • Caci International Inc /De/ • Services-computer integrated systems design • New York
CACI International Inc, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as Representatives (the “Representatives”), $270,000,000 aggregate principal amount of its 2.125% Convertible Senior Subordinated Notes Due 2014 (the “Firm Securities”). The Securities (as defined below) will be issued pursuant to an Indenture to be dated as of May 16, 2007, (the “Indenture”) between the Company and The Bank of New York, as trustee (the “Trustee”). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional $30,000,000 aggregate principal amount of its 2.125% Convertible Senior Subordinated Notes Due 2014 (the “Additional Securities”) if and to the extent that the Initial Purchasers shall have exercised the right to purchase such 2.125% Convertible Senior Subordinated Notes Due 2014 granted to the Initial Purchasers in Section 1 h
